Microbes may be used for the immunotherapy of cancer patients as a successful efficacy booster for PD-1 and PD-L1 inhibitorsCombinations of microbiomes that might boost the efficacy of immune-check inhibitors should be tested. Here, CD274 is linked to cancer.